Learn how the Broad community is contributing to the global pandemic response
Responding to COVID19
Promoting inclusion
Broad Institute believes that progress in biomedical research requires a fully inclusive community across sex, race, ethnicity, sexual orientation, age, and gender identity
Building partnerships
Broad Institute works to build and sustain international consortia to speed discovery in areas including psychiatric research, infectious disease, cardiovascular disease, and cancer
Empowering scientists
Broad Institute fosters an environment in which scientists can take risks on bold ideas with transformative potential
Reaching globally
Broad Institute is committed to addressing medical challenges across the world, including collaborating with scientists and public health experts to address important needs in developing countries
Collaborating deeply
Broad Institute is a mission-driven community that brings together researchers in medicine, biology, chemistry, computation, engineering, and mathematics from across MIT, Harvard, and Harvard-affiliated hospitals, along with collaborators around the world
Propelling the understanding and treatment of disease
Broad Institute of MIT and Harvard is empowering a revolution in biomedicine to accelerate the pace at which the world conquers disease
INSIDE BROAD
Blog / 06.9.21
Ritu Singh talks about how she helps scientists characterize the fate of their therapeutics under development, in both cells and animal models.Read more
News / 06.8.21
One type of white blood cell is abundant in severe infection and strongly curtails the immune responseRead more
News / 06.7.21
New research suggests age-related changes in blood cell chromosomes are a marker of impaired immunity.Read more
News / 06.2.21
Converting a pathogenic hemoglobin gene to a benign variant enables healthy blood cell production in an animal model of sickle cell disease.Read more
News / 06.1.21
Peptides encoded by unexplored regions of the SARS-CoV-2 genome provoke strong immune responses compared to other known peptides.Read more
News / 06.11.21
A signature of sepsis and COVID-19 outcome; digital data storage in DNA; diet's links to cancer heart disease biology; and moreRead more
Blog / 05.20.21
As a Broad researcher studying psychiatric disease, I call on scientists to help destigmatize mental illness and support patient communities.Read more
News / 05.24.21
FedRAMP certification enables federal agencies, or federally funded projects, to engage more deeply with the cloud computing system for handling sensitive data.Read more
News / 05.11.21
Joint initiative will develop comprehensive collection of molecularly and functionally characterized rare cancer tumor models to inform novel therapeutic strategiesRead more
News / 04.30.21
Eli Broad, visionary philanthropist and founder of the Broad Institute, died on April 30, 2021 in Los Angeles. He was 87. A renowned entrepreneur and the only person to have built two Fortune 500 companies in different industries, Broad was one of the most influential philanthropists in recent...Read more
News / 05.5.21
Called SETDB1, the protein could one day be targeted by new drugs for cancer patients who don’t respond to existing immunotherapies.Read more
Spotlight / 05.26.21
Watch a recording of an Equity in Biomedicine seminar with Shawneequa Callier (George Washington University), whose research focuses on issues at the intersection of bioethics, law, and genomics.Read more
Spotlight / 05.21.20
Learn about COVID-19 clinical testing and research activities at Broad, as well as data and resources for scientists studying COVID-19.Read more
Blog / 05.10.21
Student researcher Esther Elonga talks about why she wants to become a physician-scientist and support the refugee community.Read more